Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

18.6K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
18.6K
Recombinant DNA01:09

Recombinant DNA

104.9K
Overview
104.9K
Production of Pharmaceuticals01:30

Production of Pharmaceuticals

64
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
64
Vaccine Production01:23

Vaccine Production

61
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
61
Immunoprecipitation01:20

Immunoprecipitation

8.0K
Immunoprecipitation, or IP, is a widely used technique that employs protein-antibody interactions to isolate proteins or protein complexes in their native state for studying protein-protein interactions, quaternary structures, or supramolecular complexes. Various modifications of the technique, including chromatin IP, cross-linking IP, and fluorescence IP, are commonly used.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
8.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dual-mechanism anti-CD73 antibodies CR201 and CR202 targeting distinct domains for cancer immunotherapy.

Frontiers in immunology·2026
Same author

OMIP-121: Immune Phenotyping of Canine Peripheral Leukocytes by Mass Cytometry.

Cytometry. Part A : the journal of the International Society for Analytical Cytology·2026
Same author

Production of Antibody Fragments Suitable for 1:1, Site-Specific Labeling.

Methods in molecular biology (Clifton, N.J.)·2026
Same author

Structural flexibility of the human vault particle revealed by high-resolution cryo-EM and molecular dynamics simulations.

Nature communications·2026
Same author

Evaluation of nanobodies engineered with extra-cysteines for site-specific functionalization.

Journal of biotechnology·2026
Same author

Hemangiosarcoma: A Systematic Review of Biomarkers in Diagnosis, Prognosis, and Therapeutic Strategies.

Veterinary and comparative oncology·2026

Related Experiment Video

Updated: Apr 4, 2026

Laboratory Scale Production and Purification of a Therapeutic Antibody
09:54

Laboratory Scale Production and Purification of a Therapeutic Antibody

Published on: January 24, 2017

18.5K

Recombinant antibody production evolves into multiple options aimed at yielding reagents suitable for

Ario de Marco1

  • 1Department of Biomedical Sciences and Engineering, University of Nova Gorica, Glavni Trg 9, 5261, Vipava, Slovenia. Ario.DeMarco@ung.si.

Microbial Cell Factories
|September 3, 2015
PubMed
Summary

Researchers are exploring diverse recombinant antibody expression platforms to meet growing demands in diagnostics and therapy. This review critically evaluates innovative strategies for producing high-quality, application-ready antibodies.

More Related Videos

Use of High-Throughput Automated Microbioreactor System for Production of Model IgG1 in CHO Cells
08:15

Use of High-Throughput Automated Microbioreactor System for Production of Model IgG1 in CHO Cells

Published on: September 28, 2018

11.6K
Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells
10:32

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells

Published on: June 5, 2015

19.5K

Related Experiment Videos

Last Updated: Apr 4, 2026

Laboratory Scale Production and Purification of a Therapeutic Antibody
09:54

Laboratory Scale Production and Purification of a Therapeutic Antibody

Published on: January 24, 2017

18.5K
Use of High-Throughput Automated Microbioreactor System for Production of Model IgG1 in CHO Cells
08:15

Use of High-Throughput Automated Microbioreactor System for Production of Model IgG1 in CHO Cells

Published on: September 28, 2018

11.6K
Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells
10:32

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells

Published on: June 5, 2015

19.5K

Area of Science:

  • Biotechnology
  • Immunology
  • Molecular Biology

Background:

  • Antibodies are crucial in research, diagnostics, and therapy, driving demand for improved production methods.
  • Conventional and fragment antibody production faces increasing challenges in quantity and quality.
  • Diverse formats and alternative production platforms have been developed to meet these needs.

Purpose of the Study:

  • To critically compare and evaluate various recombinant antibody expression platforms.
  • To guide researchers in selecting optimal expression strategies for their needs.
  • To analyze innovative and fast-growing antibody production strategies.

Main Methods:

  • Review and critical evaluation of existing and emerging antibody expression platforms.
  • Analysis of innovative and fast-growing strategies with significant examples.
  • Comparison of novel solutions with established alternatives.

Main Results:

  • The field shows progressive diversification in antibody expression platforms.
  • There is a trend towards producing application-adapted immune reagents directly.
  • Emerging solutions offer potential for production optimization, though further data is needed for definitive judgment.

Conclusions:

  • The antibody production landscape is diversifying with novel expression platforms.
  • The focus is shifting towards generating directly usable, application-specific antibody reagents.
  • This diversification aims to streamline antibody use in research and clinical applications.